UNSPSC 51373472: Hydrocodone/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373472 Hydrocodone/phenylephrine is a Commodity code that nominally names a specific pharmaceutical product, but the recent state and local solicitations tagged under this code show little activity directly aligned with that formulation. The one relevant recent opportunity—Seminole County's naloxone and drug deactivation systems procurement—targets opioid-reversal and drug-disposal products rather than hydrocodone/phenylephrine combination cough-and-cold medications. The broader pharmaceutical procurement activity visible under this code involves generic multi-source drugs and OTC products distributed through cooperative purchasing vehicles and authorized wholesaler networks, with emphasis on pricing, product compliance, and supply-chain security rather than a single brand or formulation. State and local buyers under this code include county health agencies, state pharmaceutical-purchasing cooperatives, and participating municipalities leveraging cooperative agreements to aggregate demand across jurisdictions.

The geographic spread spans at least Minnesota (through the MMCAP cooperative vehicle administered by the Minnesota Department of Administration's Office of State Procurement, serving participating states including Oregon) and Florida (Seminole County). The most recent opportunity is the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802), issued January 20, 2026, with responses due March 26, 2026, seeking manufacturers to supply products through three authorized wholesalers with cGMP certification, DSCSA compliance, and pricing evaluated 75 percent on competitiveness, 10 percent on fixed pricing, and the remainder on administrative and technical capability. Seminole County's IFB60459723LAS (posted June 30, 2026, due July 26, 2023) sought naloxone and drug deactivation systems on an annual basis with quarterly deliveries. The mismatch between the code name and actual solicitation scope suggests this code may be incorrectly tagged for pharmaceutical procurements that fall outside the specified formulation.